Bactericidal/Permeability-Increasing Protein (rBPI21) in Patients with Hemorrhage Due to Trauma

Abstract

rBPI21 was well-tolerated and demonstrated a favorable trend in reducing the composite primary end point of mortality or serious complication through day 15, especially respiratory complications, in patients with hemorrhage due to trauma. A phase III study is currently in progress.